Bearing Point Capital LLC Has $2.60 Million Stake in SPDR S&P Biotech ETF $XBI

Bearing Point Capital LLC lifted its stake in shares of SPDR S&P Biotech ETF (NYSEARCA:XBI) by 29.2% during the fourth quarter, according to its most recent disclosure with the Securities and Exchange Commission. The institutional investor owned 21,352 shares of the exchange traded fund’s stock after purchasing an additional 4,831 shares during the period. Bearing Point Capital LLC’s holdings in SPDR S&P Biotech ETF were worth $2,603,000 at the end of the most recent reporting period.

A number of other large investors also recently modified their holdings of XBI. AQR Capital Management LLC lifted its position in shares of SPDR S&P Biotech ETF by 77.1% during the first quarter. AQR Capital Management LLC now owns 4,978 shares of the exchange traded fund’s stock worth $404,000 after purchasing an additional 2,167 shares in the last quarter. Marshall Wace LLP lifted its position in shares of SPDR S&P Biotech ETF by 102.3% during the second quarter. Marshall Wace LLP now owns 4,023 shares of the exchange traded fund’s stock worth $334,000 after purchasing an additional 179,029 shares in the last quarter. The Manufacturers Life Insurance Company acquired a new position in shares of SPDR S&P Biotech ETF during the second quarter worth approximately $260,000. Ameriprise Financial Inc. lifted its position in shares of SPDR S&P Biotech ETF by 123.0% during the second quarter. Ameriprise Financial Inc. now owns 872,796 shares of the exchange traded fund’s stock worth $72,542,000 after purchasing an additional 481,408 shares in the last quarter. Finally, EP Wealth Advisors LLC lifted its position in shares of SPDR S&P Biotech ETF by 3.7% during the second quarter. EP Wealth Advisors LLC now owns 5,379 shares of the exchange traded fund’s stock worth $446,000 after purchasing an additional 193 shares in the last quarter.

SPDR S&P Biotech ETF Trading Up 0.5%

Shares of XBI stock opened at $136.69 on Friday. SPDR S&P Biotech ETF has a 1 year low of $78.06 and a 1 year high of $139.19. The firm’s 50 day moving average is $130.99 and its 200-day moving average is $125.94. The firm has a market capitalization of $8.72 billion, a price-to-earnings ratio of 11.47 and a beta of 0.85.

SPDR S&P Biotech ETF Profile

SPDR S&P Biotech ETF (the Fund) seeks to closely match the returns and characteristics of the S&P Biotechnology Select Industry Index. The S&P Biotechnology Select Industry Index represents the biotechnology sub-industry portion of the S&P Total Markets Index. The S&P TMI tracks all the United States common stocks listed on the New York Stock Exchange, American Stock Exchange, National Association of Securities Dealers Automated Quotation (NASDAQ) National Market and NASDAQ Small Cap exchanges. The Biotech Index is a modified equal weight index.